Literature DB >> 24814686

The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.

K Ryu1, T Iriuchishima2, M Oshida3, Y Kato4, A Saito5, M Imada6, S Aizawa7, Y Tokuhashi8, J Ryu9.   

Abstract

OBJECTIVES: The purpose of this study was to reveal the accurate prevalence and related factors to the presence of calcium pyrophosphate dihydrate (CPPD) crystal deposition in cadaveric knee joints.
DESIGN: Controlled laboratory study.
METHODS: Six hundred and eight knees from 304 cadavers (332 male knees and 276 female knees, formalin fixed, Japanese anatomical specimens) were included in this study. The average age of the cadavers was 78.3 ± 10.7 years. Knees were macroscopically evaluated for the existence of CPPD, and the depth of cartilage degeneration of the femoro-tibial joint following the Outerbridge's classification. CPPD crystal was confirmed under Fourier transform infrared spectroscopy (FTIR) analysis using light microscopy. Statistical analysis was performed to reveal the correlation between the occurrence of CPPD deposition in the knee joint and gender, age, and the depth of cartilage degeneration of the femoro-tibial joint.
RESULTS: The prevalence of grossly visible CPPD crystal was 13% (79 knees). In all of these knees, CPPD crystal was confirmed under FTIR analysis. Statistical analysis showed significant correlation between the occurrence of CPPD deposition and gender (P < 0.001), and depth of cartilage degeneration in the femoro-tibial joint (P < 0.001). In the cartilage degeneration positive knees (Over grade 3 in Outerbridge's classification), average age of CPPD deposition knee was significantly higher than CPPD negative knees.
CONCLUSIONS: In this study, the prevalence of CPPD deposition disease was evaluated in a relatively large sample size of cadaveric knees. The prevalence of CPPD deposition disease was 13%, and was significantly correlated with the subject's age, gender, and severity of cartilage degeneration in the femoro-tibial joint.
Copyright © 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium pyrophosphate dihydrate (CPPD); Chondrocalcinosis; Knee; Osteoarthritis; Prevalence

Mesh:

Substances:

Year:  2014        PMID: 24814686     DOI: 10.1016/j.joca.2014.04.022

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

1.  The prevalence of chondrocalcinosis of the symphysis pubis on CT scan and correlation with calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Trusha Patel; Lawrence Ryan; Melissa Dubois; Guillermo Carrera; Keith Baynes; Rajeev Mannem; Jennifer Mulkerin; Alexis Visotcky
Journal:  Clin Rheumatol       Date:  2016-02-09       Impact factor: 2.980

2.  Fourier transform infrared spectroscopic imaging of wear and corrosion products within joint capsule tissue from total hip replacements patients.

Authors:  Songyun Liu; Deborah J Hall; Stephanie M McCarthy; Joshua J Jacobs; Robert M Urban; Robin Pourzal
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-05-17       Impact factor: 3.368

Review 3.  Imaging of calcium pyrophosphate deposition disease.

Authors:  Jennifer Miksanek; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

4.  Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography.

Authors:  Hidenori Tanikawa; Ryo Ogawa; Kazunari Okuma; Kengo Harato; Yasuo Niki; Shu Kobayashi; Takeo Nagura
Journal:  J Orthop Surg Res       Date:  2018-04-05       Impact factor: 2.359

5.  Prevalence and incidence of non-gout crystal arthropathy in southern Sweden.

Authors:  Mohaned Hameed; Aleksandra Turkiewicz; Martin Englund; Lennart Jacobsson; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2019-12-17       Impact factor: 5.156

Review 6.  Apoptosis in the Extraosseous Calcification Process.

Authors:  Federica Boraldi; Francesco Demetrio Lofaro; Daniela Quaglino
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

7.  Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.

Authors:  Laure Campillo-Gimenez; Félix Renaudin; Maud Jalabert; Pierre Gras; Marjolaine Gosset; Christian Rey; Stéphanie Sarda; Corinne Collet; Martine Cohen-Solal; Christèle Combes; Frédéric Lioté; Hang-Korng Ea
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.